Juva Life(OTC) JUVAF

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

Juva Life last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-06-29

Juva Life stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-06-17
1 month	+0%	USD 0.00	2026-05-22
3 month	+0%	USD 0.00	2026-03-25
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-06-10
3 year	-100%	USD 0.04	2023-06-30
5 year	-100%	USD 0.39	2021-06-30
Since inception	-100%	USD 0.75	2020-11-17

Juva Life Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$7.95M

Net Income (TTM)

-$6.77M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-107.52 (Low)

Dividend

$0.00

Beta (Volatility)

-107.52 (Low)

Price

$0.00

Volume

225

Open

$0.00

Price

$0.00

Volume

225

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

-107.52 (Low)

Price

$0.00

Volume

225

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

JUVAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Juva Life

Juva Life Inc. operates within the cannabis industry, focusing on the acquisition, ownership, and management of businesses in both medical and adult-use sectors. Founded in 2018 and headquartered in Vancouver, Canada, the company aims to leverage the growing demand for cannabis products.

Products and Services

Medical cannabis products for therapeutic use
Adult-use cannabis products for recreational consumers
Research and development in cannabis-related therapies

Growth Outlook

Recent quarterly revenue increased to $3.17 million in Q3 2023
Gross profit margin improved to 35.5% in Q3 2023
Strategic focus on expanding product offerings and market reach

Financial Highlights

Net income for Q3 2023 was a loss of $781,870
Total assets stood at approximately $19 million as of September 30, 2023
Current ratio of 1.11 indicates adequate short-term financial health

Juva Life Inc. is positioned in a rapidly evolving market, with a focus on both medical and recreational cannabis. The recent increase in quarterly revenue reflects the company's potential for growth, while the improvement in gross profit margin indicates operational efficiencies. Despite facing net losses, the company's asset base and current ratio suggest a stable financial position, allowing for continued investment in product development and market expansion. The strategic initiatives in place aim to capitalize on the growing demand for cannabis, making Juva Life Inc. an intriguing option for investors interested in the cannabis sector.

AI Generated • Aug 15, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Douglas Chloupek

Website

www.juvalife.com

Headquarters

Vancouver, BC V6E 4N7, CA

JUVAF Financials

Key Financial Metrics (TTM)

Gross Margin

0.76%

Operating Margin

-140.87%

Net Income Margin

-181.87%

Return on Equity

-87.14%

Return on Capital

-45.70%

Return on Assets

-51.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

225

Avg. Volume

1.04K

Financials (TTM)

Gross Profit

-$26.98K

Operating Income

-$3.86M

EBITDA

-$2.13M

Operating Cash Flow

-$4.17M

Capital Expenditure

-$992.48K

Free Cash Flow

-$5.16M

Cash & ST Invst.

$952.37K

Total Debt

$10.51M

Juva Life Performance Analysis

Juva Life annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 3,867,610	N/A
2022	2022-12-31	USD 5,763,800	49.0%

Juva Life sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	26.5%
Q1	2023-03-31	9.3%
Q2	2023-06-30	-14.4%
Q3	2023-09-30	114.8%

Juva Life annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.07	N/A
2022	2022-12-31	USD -0.06	-11.2%

Juva Life sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	10.7%
Q1	2023-03-31	43.7%
Q2	2023-06-30	-32.6%
Q3	2023-09-30	59.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$3.17M

+154.3%

Gross Profit

$1.13M

+801.7%

Gross Margin

35.45%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$781.87K

+73.1%

EBITDA

$551.44K

+132.8%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$952.37K

-73.0%

Total Debt

$10.51M

-7.9%

Accounts Receivable

$168.18K

+73.4%

Inventory

$862.35K

+23.3%

Long Term Debt

$10.51M

-5.9%

Short Term Debt

$0.00

-100.0%

Return on Assets

-51.45%

N/A

Return on Invested Capital

-46.03%

N/A

Free Cash Flow

-$250.95

+100.0%

Operating Cash Flow

-$228.66

+100.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CBDLCBD Life Sciences Inc.

CBDLCBD Life Sciences Inc.$0.00-50.00%

LRSVLink Reservations Inc.

LRSVLink Reservations Inc.$0.00+0.00%

GPFTGrapefruit USA, Inc.

GPFTGrapefruit USA, Inc.$0.00+33.33%

SHWZMedicine Man Technologies, Inc.

SHWZMedicine Man Technologies, Inc.$0.00+0.00%

AOXGAoxing Pharmaceutical Company, Inc.

AOXGAoxing Pharmaceutical Company, Inc.$0.00-40.00%

HPMMHemp Naturals, Inc.

HPMMHemp Naturals, Inc.$0.00+0.00%

SFLMSFLMaven Corp.

SFLMSFLMaven Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About JUVAF

What is the current price of Juva Life?

Juva Life is trading at $0.00 per share.

What is the 52-week range for Juva Life?

Over the past 52 weeks, Juva Life has traded between $0.00 and $0.00.

How much debt does Juva Life have?

As of the most recent reporting period, Juva Life reported total debt of $8.02M.

How much cash does Juva Life have on hand?

Juva Life reported $1.81M in cash and cash equivalents in its most recent financial results.

What is Juva Life’s dividend yield?

Juva Life does not currently have a dividend yield.

Juva Life(OTC) JUVAF

Juva Life Financials at a Glance

JUVAF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Juva Life

JUVAF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Juva Life Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JUVAF

What is the current price of Juva Life?

What is the 52-week range for Juva Life?

How much debt does Juva Life have?

How much cash does Juva Life have on hand?

What is Juva Life’s dividend yield?

Premium Investing Services